SSY GROUP (02005) has obtained the drug production registration approval for calcium levofolinic acid (25mg) for injection.
Shi Si Group (02005) announced that the group has obtained the drug production registration approval for injectable calcium levofolinate (25mg) from the China National Medical Products Administration. It belongs to the third class of chemical drugs and is considered equivalent through consistency evaluation. Calcium levofolinate is mainly used in combination with 5-fluorouracil for the treatment of gastric cancer and colorectal cancer.
SSY GROUP (02005) announced that the group has obtained the drug production registration approval for injectable calcium levofolinic acid (25mg) from the China National Medical Products Administration. It belongs to the category 3 chemical drugs and is considered equivalent to passing a consistency evaluation. Calcium levofolinic acid is mainly used in combination with 5-fluorouracil to treat gastric cancer and colorectal cancer.
Related Articles
HK Stock Market Move | GigaDevice Semiconductor Inc. (03986) rose nearly 6%, storage prices surged, institutions are optimistic about the company's strong growth momentum.
HK Stock Market Move | SF INTRA-CITY (09699) rises more than 8% in the afternoon. The daily average volume of same-city delivery services during the Spring Festival increased by more than 65% year-on-year.
DRAGON MINING (01712): The drilling activity in Uunimaki has achieved high-quality results.
HK Stock Market Move | GigaDevice Semiconductor Inc. (03986) rose nearly 6%, storage prices surged, institutions are optimistic about the company's strong growth momentum.
HK Stock Market Move | SF INTRA-CITY (09699) rises more than 8% in the afternoon. The daily average volume of same-city delivery services during the Spring Festival increased by more than 65% year-on-year.
DRAGON MINING (01712): The drilling activity in Uunimaki has achieved high-quality results.
RECOMMEND
